Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for ORALE FORMULIERUNGEN VON DEFERASIROX
Details for 2016188627
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2016188627
Title / Product Name
ORALE FORMULIERUNGEN VON DEFERASIROX
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2016188627
EP Publication Number
3124018
E-Number
955717
Language
EN
PCT Number
-
Publication Date
01.02.2017 A
20.12.2017 B1
Registration Date
20.12.2017
AT Publication Date
15.01.2018
Application Date
06.03.2014
Registration Number
-
Priorities
08.03.2013
US
201361774893 P
17.05.2013
US
201361824435 P
IPC
A61K 9/20 20060101AFI20161129BHEP
Maximum Duration of Protection
06.03.2034
Owner
NOVARTIS AG
Lichtstrasse 35
4056 Basel
CH
Representative
Representative
Schwarz & Partner Patentanwälte GmbH
Wipplingerstraße 30
1010 Wien
AT
Inventor
GHOSH, Indrajit
c/o Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936-1080
US
ZHANG, Jia-Ai
c/o Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936-1080
US
Information about Fees
Click here to load the fees